An amino terminal-truncated (dominant negative) form of ALCAM was transfected into cutaneous melanoma cells, and was found to diminish cell clustering and enhance both motility in vitro and the transition from primary tumor to tissue invasion in vivo. The gene discussed is ALCAM; the disease is cutaneous melanoma.